Predict your next investment

CareKinesis company logo
INTERNET | Internet Software & Services / Healthcare
carekinesis.com

See what CB Insights has to offer

Founded Year

2009

Stage

Other Investors | Alive

Mosaic Score

+120 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About CareKinesis

CareKinesis is a healthcare company. The company provides medication management services, including PACE pharmacy, medication risk mitigation, medication management, and dispensing, technology, and geriatric pharmacy. It is based in Moorestown, New Jersey.

CareKinesis Headquarter Location

228 Strawbridge Drive

Moorestown, New Jersey, 08057,

United States

Latest CareKinesis News

10:30 ET TRHC Hosts PACE Medical Directors at 2021 Clinical Advisory Panel Meeting

Sep 13, 2021

News provided by Share this article Share this article MOORESTOWN, N.J., Sept. 13, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC ), hosted its 16th CareKinesis Clinical Advisory Panel (CAP) Meeting, September 9-10, 2021, bringing together Program of All-Inclusive Care for the Elderly (PACE) medical directors from across the country. The two-day advisory panel was held in person in Scottsdale, AZ and virtually, enabling a compelling exchange of insights between PACE medical directors and TRHC to help prepare for changes in PACE and today's healthcare environment, to provide updates on TRHC service enhancements, and to share science and practice advances. "The CareKinesis CAP meeting provides PACE medical directors with updates on our continued success measurably improving patient outcomes through effective delivery of clinical pharmacy products and services, both inside and outside of PACE," said TRHC Co-Founder and President, Orsula V. Knowlton, PharmD. "This highly anticipated event provides us with a unique opportunity to engage with PACE medical directors to discuss opportunities to embrace enhanced models of patient care." Attendees heard an overview of TRHC's Medication Risk Mitigation (MRM) Matrix™ and participated in robust discussions focusing on medication safety and the important clinical consideration when deprescribing certain medications. PACE medical directors also participated in important case discussions on the clinical impact and benefits of Pharmacogenetics (PGx) testing for opioids and psychotropic drug utilization and prevention of adverse drug events in older adults. Other sessions included discussions on the benefits of collaborative practice agreements between pharmacists and physicians, optimizing management of kidney failure in PACE, and keeping PACE participants safe during transitions of care. In addition, attendees learned more about TRHC's latest peer-reviewed publications. They received an overview of current research from TRHC Precision Pharmacotherapy Research & Development Institute which will enable PACE medical directors to apply the latest data to their use of the MedWise Risk Score™ in collaboration with board-certified pharmacists. The CAP Meeting is a training and education event for PACE medical directors. CME, ACPE and CNE continuing education credits are available to participants. PACE is a managed care program that provides a comprehensive, all-inclusive package of medical and supportive services to individuals aged 55 or older who are certified by their state to need nursing home care, are able to live safely in the community at the time of enrollment, and live in a PACE service area. CareKinesis is the first national PACE-centric, medication management and distribution pharmacy that focuses on reducing medication-related risk while enhancing economic, clinical, and humanistic outcomes. About Tabula Rasa HealthCare Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC ) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care. For more information, visit TRHC.com . SOURCE Tabula Rasa HealthCare, Inc. Related Links

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CareKinesis Patents

CareKinesis has filed 3 patents.

The 3 most popular patent topics include:

  • Diabetes
  • Hepatology
  • Intensive care medicine
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/22/2014

7/21/2020

Diabetes, Medical terminology, Pharmaceuticals policy, Syndromes, Hepatotoxins

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/22/2014

00/00/0000

00/00/0000

Grant Date

7/21/2020

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Diabetes, Medical terminology, Pharmaceuticals policy, Syndromes, Hepatotoxins

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CareKinesis Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CareKinesis Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.